HIGH RISK NEUROBLASTOMA
Clinical trials for HIGH RISK NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: first test of 'Living Drug' therapy
Disease control Recruiting nowThis is the first time researchers are testing a new type of cell therapy called GPC2 CAR T in children. The trial aims to find a safe dose for kids with advanced neuroblastoma or metastatic retinoblastoma that has come back or hasn't responded to all other standard treatments. D…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with aggressive cancer: adding drug to first treatment
Disease control Recruiting nowThis trial is testing if adding a new drug called naxitamab to the standard first round of chemotherapy can better control a serious childhood cancer called high-risk neuroblastoma. It will involve about 93 children and young adults up to age 21 who are newly diagnosed. The goal …
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with tough cancer: less chemo, same fight?
Disease control Recruiting nowThis study is testing a new, reduced chemotherapy plan called N10 for children with high-risk neuroblastoma, a serious childhood cancer. The goal is to see if this less intense treatment is still effective and safe for patients under 19 years old. Researchers want to find out if …
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for kids with incurable cancer: first trial of groundbreaking cell therapy begins
Disease control Recruiting nowThis is the first-ever study in people to test a new type of CAR-T cell therapy called PHOX2B PC-CAR T for children with advanced, high-risk neuroblastoma that has come back or not responded to other treatments. The main goal is to find a safe dose and see if the treatment can be…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test vaccine to keep deadly childhood cancer at bay
Disease control Recruiting nowThis study is testing a two-part treatment to prevent high-risk neuroblastoma from returning in patients who are currently in remission. It combines a vaccine designed to train the immune system to attack cancer cells with an oral supplement (β-glucan) that may boost the immune r…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New immune cell therapy tested for tough childhood cancer
Disease control Recruiting nowThis early-stage trial is testing a new treatment for children and young adults whose high-risk neuroblastoma has come back or hasn't responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then in…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Roberto Chiarle • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC
-
New program aims to lift financial burden for families battling childhood cancer
Symptom relief Recruiting nowThis study is testing whether adding a special support program to usual care helps low-income families whose children have high-risk neuroblastoma. About 84 families will be randomly assigned to receive either the usual care or the usual care plus the new support program for 6 mo…
Matched conditions: HIGH RISK NEUROBLASTOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Tracking the hidden costs of survival: study probes health of young cancer survivors
Knowledge-focused Recruiting nowThis study aims to understand the long-term health of children and young adults who survived high-risk neuroblastoma after receiving modern treatments. Researchers will check participants' heart, nerve, and organ function to see if any late health problems develop. The goal is to…
Matched conditions: HIGH RISK NEUROBLASTOMA
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC